Artelo Biosciences (ARTL) Payables (2015 - 2025)

Artelo Biosciences (ARTL) has reported Payables for 11 consecutive years, with $3.5 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Payables rose 107.16% year-over-year to $3.5 million in Q4 2025; TTM through Dec 2025 was $3.5 million, a 107.16% increase from a year earlier, with the FY2025 full-year figure at $3.5 million, up 107.16% from the prior year.
• Payables was $3.5 million for Q4 2025 at Artelo Biosciences, down from $4.7 million in the prior quarter.
• Over five years, Payables peaked at $4.8 million in Q2 2025 and troughed at $5000.0 in Q1 2021.
• A 5-year average of $1.3 million and a median of $814000.0 in 2023 frame the typical range for Payables.
• The widest YoY moves for Payables: up 5336.29% in 2021, down 61.01% in 2021.
• Over 5 years, Payables stood at $628000.0 in 2021, then soared by 52.55% to $958000.0 in 2022, then grew by 29.23% to $1.2 million in 2023, then surged by 35.38% to $1.7 million in 2024, then jumped by 107.16% to $3.5 million in 2025.
• The last three Payables figures came in at $3.5 million (Q4 2025), $4.7 million (Q3 2025), and $4.8 million (Q2 2025), per Business Quant data.